RBM12
Basic information
Region (hg38): 20:35648925-35664956
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Schizophrenia 19 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 28628109 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBM12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 43 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 7 | 7 |
Variants in RBM12
This is a list of pathogenic ClinVar variants found in the RBM12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-35652547-T-C | not specified | Uncertain significance (May 30, 2024) | ||
20-35652576-T-C | not specified | Uncertain significance (Sep 11, 2024) | ||
20-35652603-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
20-35652648-T-C | not specified | Uncertain significance (Dec 22, 2023) | ||
20-35652746-T-G | not specified | Uncertain significance (Mar 20, 2024) | ||
20-35652764-T-C | Benign (Dec 31, 2019) | |||
20-35652790-CA-C | Schizophrenia 19 | Pathogenic (Aug 17, 2017) | ||
20-35652813-G-T | not specified | Uncertain significance (Apr 27, 2022) | ||
20-35652812-T-TGGGCCA | RBM12-related disorder | Benign (Dec 13, 2019) | ||
20-35652818-A-G | RBM12-related disorder | Likely benign (Nov 26, 2019) | ||
20-35652818-AGGGCCG-A | RBM12-related disorder | Benign (Oct 31, 2019) | ||
20-35652823-C-T | not specified | Uncertain significance (Sep 15, 2021) | ||
20-35652835-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
20-35652914-C-T | Benign (Jul 05, 2018) | |||
20-35652915-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
20-35652922-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
20-35652940-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
20-35652946-C-A | Schizophrenia 19 | Pathogenic (Aug 17, 2017) | ||
20-35653063-T-A | not specified | Uncertain significance (Aug 12, 2021) | ||
20-35653076-A-T | not specified | Uncertain significance (Oct 08, 2024) | ||
20-35653120-G-A | Uncertain significance (Feb 01, 2024) | |||
20-35653261-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
20-35653270-C-G | not specified | Uncertain significance (Jun 04, 2024) | ||
20-35653299-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
20-35653359-G-A | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBM12 | protein_coding | protein_coding | ENST00000374114 | 1 | 16032 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00211 | 0.980 | 125723 | 0 | 25 | 125748 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.24 | 443 | 523 | 0.847 | 0.0000280 | 6087 |
Missense in Polyphen | 67 | 105.27 | 0.63647 | 1367 | ||
Synonymous | -0.147 | 195 | 192 | 1.01 | 0.0000108 | 2015 |
Loss of Function | 2.08 | 7 | 16.0 | 0.438 | 9.35e-7 | 245 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000274 | 0.000271 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.0000974 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Disease
- DISEASE: Schizophrenia 19 (SCZD19) [MIM:617629]: A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder. {ECO:0000269|PubMed:28628109}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.186
Intolerance Scores
- loftool
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.47
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.413
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbm12
- Phenotype
- growth/size/body region phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- Cellular component
- nucleoplasm
- Molecular function
- RNA binding;protein binding